Large-scale testing (Phase 3)UnknownNCT02409199What this trial is testingApatinib Versus Docetaxol Patients With Advanced Gastric CancerWho this might be right forGastric Carcinoma Shanghai Zhongshan Hospital 66
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07243938What this trial is testingPhase II Basket Trial: Zanidatamab Plus Tislelizumab in HER2-Positive GI Tumors (UNION-HER2-BASKET)Who this might be right forLocally Advanced Rectal Cancer (LARC)Locally Advanced Gastric/Gastroesophageal Junction AdenocarcinomaMetastatic Colorectal Cancer (mCRC)+1 more Tao Zhang 70
Testing effectiveness (Phase 2)Looking for participantsNCT05671822What this trial is testingPh1b/2 Study of the Safety and Efficacy of SHR-A1811 Combinations in Advanced HER2 Expression Gastric CancerWho this might be right forHER2 Expression Gastric Cancer/Gastroesophageal Junction Adenocarcinoma Suzhou Suncadia Biopharmaceuticals Co., Ltd. 258
Testing effectiveness (Phase 2)Looking for participantsNCT07176312What this trial is testingZanidatamab in Combination With Pembrolizumab and Chemotherapy in HER2 and PD-L1 Positive Metastatic Gastroesophageal Adenocarcinoma (GEA) PatientsWho this might be right forGastroesophageal AdenocarcinomaFirst Line TherapyHER2 + Gastric Cancer+2 more Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest 80
Testing effectiveness (Phase 2)WithdrawnNCT03592407What this trial is testingEpacadostat and Pembrolizumab Before Surgery in Treating Participants With Stage II-III Esophageal or Gastroesophageal CancerWho this might be right forEsophageal Squamous Cell CarcinomaEsophageal AdenocarcinomaGastroesophageal Junction Adenocarcinoma City of Hope Medical Center
Not applicableLooking for participantsNCT06846996What this trial is testingReal-world Effectiveness and Safety of Trastuzumab Deruxtecan in Patients With Locally Advanced or Metastatic HER2-positive Gastric or Gastroesophageal Junction Adenocarcinoma in ChinaWho this might be right forHER2-positive Gastric CancerHER2-positive Gastroesophageal Junction Daiichi Sankyo 260
Large-scale testing (Phase 3)Looking for participantsNCT07043400What this trial is testingInvestigate Tislelizumab Administered as Subcutaneous Injection Versus Intravenous Infusion Plus Chemotherapy in Patients With Unresectable or Metastatic Gastric or Gastroesophageal Junction AdenocarcinomaWho this might be right forMetastatic Gastric AdenocarcinomaGastroesophageal Junction Adenocarcinoma BeOne Medicines 351
Testing effectiveness (Phase 2)Looking for participantsNCT05640609What this trial is testingCapeox Regimen Combined With Sintilimab and Bevacizumab for Gastric CancerWho this might be right forStomach Neoplasm West China Hospital 57
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06586294What this trial is testingAnti-PD-1 and LAG-3 Bispecific Antibody(AK129) Combined With Chemotherapy With or Without Cadonilimab in the First-line Treatment of Unresectable Locally Advanced or Metastatic G/ GEJ AdenocarcinomaWho this might be right forGastric AdenocarcinomaGastroesophageal Junction Adenocarcinoma Akeso 294
Testing effectiveness (Phase 2)Study completedNCT01611857What this trial is testingPhase I/II Trial of Tivantinib With FOLFOX for the Treatment of Advanced Solid Tumors and Previously Untreated Metastatic Adenocarcinoma of the Distal Esophagus, Gastroesophageal Junction or StomachWho this might be right forMalignant Solid TumourGastroesophageal Cancer SCRI Development Innovations, LLC 49
Testing effectiveness (Phase 2)Looking for participantsNCT06962137What this trial is testingPhase II RAINSPOT: Zolbetuximab-Paclitaxel-Ramucirumab for CLDN18.2 Positive Gastro-esophageal CancerWho this might be right forGastric Cancer Adenocarcinoma MetastaticGastric Adenocarcinoma and Gastroesophageal Junction Adenocarcinoma Universitaire Ziekenhuizen KU Leuven 100
Large-scale testing (Phase 3)Study completedNCT00680901What this trial is testingLOGiC - Lapatinib Optimization Study in ErbB2 (HER2) Positive Gastric Cancer: A Phase III Global, Blinded Study Designed to Evaluate Clinical Endpoints and Safety of Chemotherapy Plus LapatinibWho this might be right forNeoplasms, Gastrointestinal Tract Novartis Pharmaceuticals 545
Early research (Phase 1)Study completedNCT04805307What this trial is testingSafety, Tolerability, Pharmacokinetics, and Preliminary Efficacy, Phase 1 Study of CMG901Who this might be right forAdvanced Solid TumorGastric Cancer(Including Gastroesophageal Junction Adenocarcinoma)Pancreatic Cancer Keymed Biosciences Co.Ltd 176
Testing effectiveness (Phase 2)Study completedNCT00940225What this trial is testingStudy of Cabozantinib (XL184) in Adults With Advanced MalignanciesWho this might be right forSolid TumorsCancer Exelixis 730
Testing effectiveness (Phase 2)Study completedNCT00780494What this trial is testingPh II of Capecitabine, Carboplatin & Bevacizumab for Gastroesophageal Junction & Gastric CarcinomaWho this might be right forStomach CancerGastric (Stomach) CancerNeoplasm of Cardioesophageal Junction+1 more Stanford University 35
Large-scale testing (Phase 3)Study completedNCT03675737What this trial is testingPembrolizumab (MK-3475) Plus Chemotherapy Versus Placebo Plus Chemotherapy in Participants Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma (MK-3475-859/KEYNOTE-859)Who this might be right forStomach Neoplasms Merck Sharp & Dohme LLC 1,579
Testing effectiveness (Phase 2)Study completedNCT02340975What this trial is testingA Phase 1b/2 Study of MEDI4736 With Tremelimumab, MEDI4736 or Tremelimumab Monotherapy in Gastric or GEJ AdenocarcinomaWho this might be right forGastric or Gastroesophageal Junction Adenocarcinoma MedImmune LLC 114
Testing effectiveness (Phase 2)Looking for participantsNCT06767800What this trial is testingA Clinical Trial Evaluating TQB2102 for Injection in Combination With Behmosubaisumab/Payamprolizumab With or Without Chemotherapy in Unresectable Locally Advanced, Recurrent, or Metastatic Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Gastroesophageal AdenocarcinomaWho this might be right forGastroesophageal Adenocarcinoma Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd. 204
Not applicableUnknownNCT04915807What this trial is testingReal-world Data (RWD) of Ramucirumab Plus PaclitaxelWho this might be right forGastric CancerGastroesophageal Junction Adenocarcinoma Hallym University Medical Center 222
Testing effectiveness (Phase 2)Looking for participantsNCT05086692What this trial is testingA Beta-only IL-2 ImmunoTherapY StudyWho this might be right forAdvanced Solid TumorUnresectable Solid TumorClear Cell Renal Cell Carcinoma+34 more Medicenna Therapeutics, Inc. 115